Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$15.9 - $21.15 $871,320 - $1.16 Million
-54,800 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$13.3 - $17.55 $67,138 - $88,592
-5,048 Reduced 8.43%
54,800 $837,000
Q4 2020

Feb 02, 2021

SELL
$12.08 - $17.46 $14,496 - $20,952
-1,200 Reduced 1.97%
59,848 $844,000
Q3 2020

Nov 05, 2020

BUY
$13.62 - $17.66 $85,097 - $110,339
6,248 Added 11.4%
61,048 $957,000
Q2 2020

Aug 12, 2020

BUY
$13.04 - $23.23 $465,527 - $829,311
35,700 Added 186.91%
54,800 $960,000
Q4 2019

Jan 27, 2020

BUY
$15.24 - $25.09 $291,084 - $479,219
19,100 New
19,100 $479,000

Others Institutions Holding CRNX

About Crinetics Pharmaceuticals, Inc.


  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.94B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.